Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31bbbde6598866cfb419981a094e844e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61eb3919ad33340b459b94f531bf440c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2016-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93c647eca6461b481d175342d6fccf20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a75e4cfab30aee4f461224d7b9057ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f6749d58d6f6b31dee46f50bf1fb663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c72daf2245530d55518b6426199da53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db96961fccd97703088d1f30e2f0da72 |
publicationDate |
2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-3048971-A1 |
titleOfInvention |
BISPECIFIC PEPTIDE CONSTRUCTS AND THEIR USE IN THE TREATMENT OF DISEASES, IN PARTICULAR IMFLAMMATORY DISEASES |
abstract |
The invention relates to a peptide construct comprising at least one type C lectin binding domain and at least one TLR2 binding domain and having a molecular weight of less than 200 kDa. |
priorityDate |
2016-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |